Healthcare provider profile · identity verified

David O. Barbe, MD

Family Practice · MOUNTAIN GROVE, MO · NPI 1871667618

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	498	132
Atorvastatin Calcium	Atorvastatin Calcium	409	129
Alprazolam	Alprazolam	332	77
Levothyroxine Sodium	Levothyroxine Sodium	312	98
Lisinopril	Lisinopril	277	85
Tramadol Hcl	Tramadol Hcl	244	69
Omeprazole	Omeprazole	222	66
Gabapentin	Gabapentin	204	64
Amlodipine Besylate	Amlodipine Besylate	197	69
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	189	50
Albuterol Sulfate Hfa	Albuterol Sulfate	177	49
Losartan Potassium	Losartan Potassium	172	50
Famotidine	Famotidine	169	34
Duloxetine Hcl	Duloxetine Hcl	149	26
Simvastatin	Simvastatin	141	41
Trazodone Hcl	Trazodone Hcl	129	38
Metoprolol Tartrate	Metoprolol Tartrate	125	33
Tamsulosin Hcl	Tamsulosin Hcl	122	34
Rosuvastatin Calcium	Rosuvastatin Calcium	120	39
Pregabalin	Pregabalin	119	32
Furosemide	Furosemide	114	42
Glipizide	Glipizide	114	34
Clonazepam	Clonazepam	112	25
Metformin Hcl	Metformin Hcl	112	33
Lorazepam	Lorazepam	108	33
Tizanidine Hcl	Tizanidine Hcl	108	38
Hydrochlorothiazide	Hydrochlorothiazide	107	35
Fluticasone Propionate	Fluticasone Propionate	105	31
Metoprolol Succinate	Metoprolol Succinate	93	30
Lovastatin	Lovastatin	92	24
Potassium Chloride	Potassium Chloride	90	27
Zolpidem Tartrate	Zolpidem Tartrate	85	20
Eliquis	Apixaban	83	17
Pantoprazole Sodium	Pantoprazole Sodium	83	28
Oxycodone Hcl	Oxycodone Hcl	82	24
Clopidogrel	Clopidogrel Bisulfate	76	20
Carvedilol	Carvedilol	70	22
Meloxicam	Meloxicam	66	25
Sertraline Hcl	Sertraline Hcl	66	23
Montelukast Sodium	Montelukast Sodium	65	suppressed
Testosterone Cypionate	Testosterone Cypionate	57	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	16
Donepezil Hcl	Donepezil Hcl	54	suppressed
Baclofen	Baclofen	51	11
Citalopram Hbr	Citalopram Hydrobromide	49	18
Mirtazapine	Mirtazapine	49	15
Warfarin Sodium	Warfarin Sodium	49	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	20
Ozempic	Semaglutide	48	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	16
Metformin Hcl Er	Metformin Hcl	46	15
Ondansetron Odt	Ondansetron	46	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	44	suppressed
Morphine Sulfate Er	Morphine Sulfate	42	12
Diazepam	Diazepam	40	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Allopurinol	Allopurinol	38	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	11
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Spironolactone	Spironolactone	38	13
Alendronate Sodium	Alendronate Sodium	37	11
Oxybutynin Chloride Er	Oxybutynin Chloride	36	12
Ezetimibe	Ezetimibe	35	11
Ibuprofen	Ibuprofen	35	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Buspirone Hcl	Buspirone Hcl	34	11
Estradiol	Estradiol	34	suppressed
Glimepiride	Glimepiride	34	14
Dicyclomine Hcl	Dicyclomine Hcl	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Finasteride	Finasteride	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Atenolol	Atenolol	28	11
Amitriptyline Hcl	Amitriptyline Hcl	27	11
Colchicine	Colchicine	26	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Topiramate	Topiramate	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	11
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Linzess	Linaclotide	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Naproxen	Naproxen	20	suppressed
Prednisone	Prednisone	20	15
Rizatriptan	Rizatriptan Benzoate	20	suppressed
Temazepam	Temazepam	20	suppressed
Carisoprodol	Carisoprodol	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Cilostazol	Cilostazol	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Digoxin	Digoxin	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	11
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Enulose	Lactulose	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Olanzapine Odt	Olanzapine	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Savella	Milnacipran Hcl	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error